Page 4 - மருந்துகள் வைத்திருத்தல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருந்துகள் வைத்திருத்தல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருந்துகள் வைத்திருத்தல் Today - Breaking & Trending Today

Santhera Announces Settlement of Convertible Bond Exchange Offer on May 4, 2021


By Notice of Repurchase Offer dated March 25, 2021 (the
Notice), Santhera Pharmaceuticals Holding AG announced an offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the
2017/22 Bonds) on the terms set out in the Notice (the
Exchange
Offer). The Exchange Offer was accepted by bondholders with respect to 2017/22 Bonds with an aggregate principal amount of CHF 44,845,000, corresponding to 74.7% of all 2017/22 Bonds in circulation.
S
ettlement
Santhera has decided to settle the Exchange Offer on May 4, 2021. The Exchange Offer will be settled via the banking system. Upon settlement, all offer conditions (b), (c), (d) and (e), as set out in the Notice, which have not been satisfied until that date will be waived. ....

Switzerland General , United States , United Kingdom , Eva Kalias , Santhera Pharmaceuticals , Swiss Financial Services Act Fin , Head External Communications , Financial Services , Santhera Pharmaceuticals Holding , Us Securities Exchange , Stifel Nicolaus Europe , European Union Withdrawal , Chiesi Group , Exchange Offer On , Exchange Offer , Convertible Bonds , Repurchase Offer , Nicolaus Europe Limited , Unsecured Convertible Bonds , Listing Prospectus Regarding , New Bonds , Annual General , North American , Head External , Pharmaceuticals Holding , Exchange Act ,

Investegate |Santhera Pharmaceuticals Holdi Announcements | Santhera Pharmaceuticals Holdi: Santhera Announces Settlement of Convertible Bond Exchange Offer on May 4, 2021


By Notice of Repurchase Offer dated March 25, 2021 (the
Notice), Santhera Pharmaceuticals Holding AG announced an offer to exchange its outstanding CHF 60 million 5% Convertible Bonds due 2022 (the
2017/22 Bonds) on the terms set out in the Notice (the
Exchange
Offer). The Exchange Offer was accepted by bondholders with respect to 2017/22 Bonds with an aggregate principal amount of CHF 44,845,000, corresponding to 74.7% of all 2017/22 Bonds in circulation.
S
ettlement
Santhera has decided to settle the Exchange Offer on May 4, 2021. The Exchange Offer will be settled via the banking system. Upon settlement, all offer conditions (b), (c), (d) and (e), as set out in the Notice, which have not been satisfied until that date will be waived. ....

Switzerland General , United States , United Kingdom , Eva Kalias , Santhera Pharmaceuticals , Swiss Financial Services Act Fin , Head External Communications , Financial Services , Santhera Pharmaceuticals Holding , Us Securities Exchange , Stifel Nicolaus Europe , European Union Withdrawal , Chiesi Group , Exchange Offer On , Santhera Announces Settlement , Convertible Bond Exchange Offer , Exchange Offer , Convertible Bonds , Repurchase Offer , Nicolaus Europe Limited , Unsecured Convertible Bonds , Listing Prospectus Regarding , New Bonds , Annual General , North American , Head External ,

Here's a Popular Robinhood Penny Stock You'll Want to Have on Your Radar

Here's a Popular Robinhood Penny Stock You'll Want to Have on Your Radar
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Tonix Pharmaceuticals Holding , Pharmaceuticals Holding , Gilead Science Veklury , மருந்துகள் வைத்திருத்தல் ,